Supernus Corp (SUPN): Narx/daromad koeffitsiyenti
Barqaror taqsimot kanallari Supernus Pharmaceuticals (SUPN) uchun neyropreparatlar yetkazib berishdagi uzilishlarni bartaraf etadi. Taxminiy narx-savdo nisbati aktivlarning bozor qiymatini vizuallashtiradi, bunda 2.70 darajasi joriy qiymatni ifodalaydi. Bozor ulushini himoya qilish noyob modda chiqarish formulalariga asoslangan. Yuqori masshtablanuvchanlik muvaffaqiyatli klinik sinovlardan so'ng mahsulotlarning keyingi global tijoratlashtirilishi orqali ta'minlanadi.
Supernus Corp (SUPN) kompaniyasining tahliliy kesimlari
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- kompaniyaning balans qiymati tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Supernus Pharmaceuticals|SUPN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati supernus.com|SUPN - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Supernus|SUPN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Supernus|Tezkor likvidlik koeffitsiyenti supernus.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
SUPN - Sof foyda|Kelajakdagi foyda Supernus Pharmaceuticals|SUPN - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Supernus Pharmaceuticals|SUPN - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Supernus Pharmaceuticals|SUPN - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Supernus|SUPN - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi supernus.com|SUPN - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Supernus Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:Supernus Pharmaceuticals, Inc., SUPN
Daromadlari markaziy nerv tizimi (CNS) terapiya dori vositalarini yetkazib berish bo'yicha sog'liqni saqlash tizimlari bilan tuzilgan uzoq muddatli shartnomalarga bog'liq bo'lgan Supernus Pharmaceuticals (SUPN) uchun ushbu grafikdagi P/S ko'rsatkichlari bir dollar daromadning bozor qiymatini aks ettiradi. Bozor kapitalizatsiyasining savdolarga nisbati biznes uchun to'langan premiumni baholash imkonini beradi, bunda past qiymatlar himoya buferini yaratadi va yuqori qiymatlar tendentsiya almashinuvi paytida korreksiya xavfini oshiradi.
Supernus Pharmaceuticals raqobatchilari
BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|CPRX (Catalyst Pharmaceuticals Inc) - P/S multiplikatori|DNLI: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati harmonybiosciences.com (HRMY)|Biohaven - Kapitalizatsiya va daromad nisbati|P/S multiplikatori AMLX (amylyx.com)|Trevi Pharma (TRVI) - Sotuvga nisbatan narx|Praxis Corp - P/S multiplikatori|Anavex Corp (AVXL) - Kapitalizatsiyaning daromadga nisbati|CBLL: P/S multiplikatori|Prothena Biosciences - Bozor kapitallashuvining daromadga nisbati|ALEC (alector.com) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANNX (Annexon Biosciences)|Narxning daromadga nisbati Omeros Corporation (OMER)|Neurogene Corp - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati AC Immune S.A. ACIU|Narx/daromad koeffitsiyenti Voyager Therapeutics (VYGR)|Neumora - P/S multiplikatori|Narxning sotuvga nisbati SCLX|Tevogen Bio Inc. (TVGN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati ACOG|CGTX (cogrx.com) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati inhibikase.com (IKT)|Narxning daromadga nisbati Cassava Sciences Inc (SAVA)|Narx/daromad koeffitsiyenti Assertio|P/S multiplikatori COYA (Coya Therapeutics, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati VTGN (VistaGen Therapeutics Inc)|OVID: Kapitalizatsiyaning daromadga nisbati|ABOS: Narxning daromadga nisbati|CervoMed (CRVO) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PEPG (PepGen)|Kapitalizatsiyaning daromadga nisbati JUNS (Jupiter Neurosciences, Inc.)|P/S multiplikatori relmada.com (RLMD)|Narxning daromadga nisbati Annovis Bio Corp ANVS|GRCE: Kapitalizatsiya va daromad nisbati|AIFF - Narxning daromadga nisbati|KLTO (anewmeds.com) - Kapitalizatsiya va daromad nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalizatsiyaning daromadga nisbati|revivapharma.com - Bozor kapitallashuvining daromadga nisbati|MTVA (metaviatx.com) - P/S multiplikatori|NRXS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HSDT|PASG - Sotuvga nisbatan narx|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV: Kapitalizatsiya va daromad nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Addex Therapeutics Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|Alzamend Neuro, Inc. (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati
